Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Marinus Pharmaceuticals Inc (NASDAQ: MRNS) was $0.32 for the day, up 0.84% from the previous closing price of $0.32. In other words, the price has increased by $0.84 from its previous closing price. On the day, 0.87 million shares were traded. MRNS stock price reached its highest trading level at $0.34 during the session, while it also had its lowest trading level at $0.312.
Ratios:
Our analysis of MRNS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 1.66.
Robert W. Baird Downgraded its Outperform to Neutral on April 16, 2024, whereas the target price for the stock was revised from $20 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 05 ’24 when Pfanstiel Steven sold 4,657 shares for $1.13 per share. The transaction valued at 5,262 led to the insider holds 79,773 shares of the business.
Shafer Christina sold 3,820 shares of MRNS for $4,355 on Aug 05 ’24. The CHIEF COMMERCIAL OFFICER now owns 67,406 shares after completing the transaction at $1.14 per share. On Aug 05 ’24, another insider, MANNING MARTHA E, who serves as the SVP, GEN. COUNSEL & CORP. SEC. of the company, sold 3,621 shares for $1.13 each. As a result, the insider received 4,092 and left with 60,263 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRNS now has a Market Capitalization of 17935320 and an Enterprise Value of 50216484. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.57. Its current Enterprise Value per Revenue stands at 1.659 whereas that against EBITDA is -0.39.
Stock Price History:
Over the past 52 weeks, MRNS has reached a high of $11.26, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is -70.67%, while the 200-Day Moving Average is calculated to be -89.23%.
Shares Statistics:
MRNS traded an average of 2.47M shares per day over the past three months and 1156320 shares per day over the past ten days. A total of 54.58M shares are outstanding, with a floating share count of 41.84M. Insiders hold about 24.18% of the company’s shares, while institutions hold 62.83% stake in the company. Shares short for MRNS as of 1730332800 were 5664347 with a Short Ratio of 2.30, compared to 1727654400 on 3221631. Therefore, it implies a Short% of Shares Outstanding of 5664347 and a Short% of Float of 10.319999600000001.
